论文部分内容阅读
目的:研究胰岛素泵联合动态血糖监测治疗新诊断重症2型糖尿病的临床效果观察。方法:选取2012年6月～2013年6月间入院诊治的重症2型糖尿病患者68例,随机分为A组(34例)、B(34例)。其中A组应用动态血糖监测﹙CGMS﹚联合胰岛素泵﹙CSII﹚治疗,B组应用每天八次采集指血监测血糖联合胰岛素泵治疗,治疗结束后观察2组患者血糖水平、血糖达标时间、胰岛素总剂量及低血糖的发生率。结果:2组患者经治疗后血糖均得到一定的控制,但A组血糖控制水平更为理想,胰岛素总剂量、血糖达标时间、发生低血糖次数均明显低于B组。结论:动态血糖监测能够实时监测体内血糖水平变化情况,指导胰岛素泵进行应用,对2型糖尿病患者血糖水平的控制效果良好。
Objective: To study the clinical effect of insulin pump combined with ambulatory blood glucose monitoring in the newly diagnosed severe type 2 diabetes mellitus. Methods: Sixty-eight patients with severe type 2 diabetes admitted to our hospital from June 2012 to June 2013 were randomly divided into A group (34 cases) and B (34 cases). Group A was treated with CGMS combined with insulin pump (CSII). Group B received blood glucose monitoring and insulin pump eight times a day. After the treatment, blood glucose, blood glucose level, total insulin Dose and incidence of hypoglycemia. Results: After treatment, blood glucose was controlled in both groups. However, the blood glucose level in group A was more satisfactory. The total dose of insulin, the time of reaching blood glucose level and the frequency of hypoglycemia were significantly lower than those in group B. Conclusion: The dynamic blood glucose monitoring can monitor the change of blood glucose level in real time, guide the application of insulin pump, and control the blood sugar level in patients with type 2 diabetes well.